SCHEMBL26147452

SCHEMBL26147452

CC(C)OCC(=O)NCCN(C)CCNC(=O)C(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LGALS1 P09382 1/20 0.36
NPSR1 Q6W5P4 1/20 0.33
KMT2A Q03164 3/20 0.33
CYP2D6 P10635 2/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
ALDH1A1 P00352 2/20 0.32
USP2 O75604 1/20 0.32
TSHR P16473 1/20 0.32
NQO2 P16083 1/20 0.32
MTNR1A P48039 1/20 0.32
MTNR1B P49286 1/20 0.32
CYP1A2 P05177 1/20 0.31
DNM1 Q05193 1/20 0.31
MEN1 O00255 1/20 0.31
LMNA P02545 2/20 0.31
CYP3A4 P08684 1/20 0.31
GAA P10253 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17972720 0.92 LGALS1 (0.40) LGALS1NPSR1KMT2ACYP2D6CYP2C19
SCHEMBL14366096 0.87 ALDH1A1 (0.38) KMT2ACYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL25089951 0.86 SIGMAR1 (0.37) LGALS1NPSR1KMT2ACYP2D6CYP2C19
SCHEMBL24941942 0.84 LGALS1 (0.36) LGALS1NPSR1KMT2ACYP2D6CYP2C19
SCHEMBL21106971 0.83 KMT2A (0.42) KMT2ACYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL21107576 0.83 KMT2A (0.42) KMT2ACYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL16316501 0.83 USP2 (0.43) KMT2ACYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL21106815 0.82 FAAH (0.44) KMT2ACYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL21107462 0.82 FAAH (0.44) KMT2ACYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL21106814 0.82 FAAH (0.44) KMT2ACYP2D6CYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150974-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. 2023-05-18 US disclosed
US-20230150974-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150974-A1 COMPOUNDS AND USES THEREOF VHL, CLN6, TFEB LGALS1 4493/4885NPSR1 4599/4885KMT2A 792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.